{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:58:11Z","timestamp":1790837891117,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1497-5","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T12:03:08Z","timestamp":1565697788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection"],"prefix":"10.1186","volume":"20","author":[{"given":"Marcus Faria","family":"Lasmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Santana","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Augusto","family":"Nogueira-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel A.","family":"Fabreti-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Gomes","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaldo","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"6","key":"1497_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1159\/000351643","volume":"37","author":"UM Thiyagarajan","year":"2013","unstructured":"Thiyagarajan UM, Ponnuswamy A, Bagul A. Thymoglobulin and its use in renal transplantation: a review. Am J Nephrol. 2013;37(6):586\u2013601.","journal-title":"Am J Nephrol"},{"issue":"14","key":"1497_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s40265-014-0277-6","volume":"74","author":"M Mohty","year":"2014","unstructured":"Mohty M, Bacigalupo A, Saliba F, Zuckermann A, Morelon E, Lebranchu Y. New direction for rabbit antilymocyre globulin (thymoglobulin\u00ae) in solid organ transplants, stem cell transplants and autoimmunty. Drugs. 2014;74(14):1605\u201334.","journal-title":"Drugs."},{"issue":"2","key":"1497_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.tp.0000269725.74189.b9","volume":"84","author":"G Opelz","year":"2007","unstructured":"Opelz G, D\u00f6hler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation. 2007;84(2):137\u201343.","journal-title":"Transplantation."},{"issue":"5","key":"1497_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","volume":"82","author":"AD Kirk","year":"2006","unstructured":"Kirk AD. Induction immunosuppression. Transplantation. 2006;82(5):593\u2013602.","journal-title":"Transplantation."},{"issue":"12","key":"1497_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1592\/phco.26.12.1771","volume":"26","author":"KL Hardinger","year":"2006","unstructured":"Hardinger KL. Rabbit antilinphacyte globuin induction therapy in adult renal transplantation. Pharmacotherapy. 2006;26(12):1771\u201383.","journal-title":"Pharmacotherapy."},{"issue":"10","key":"1497_CR6","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1681\/ASN.2006050422","volume":"17","author":"M Lopes","year":"2006","unstructured":"Lopes M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol. 2006;17(10):2844\u201353.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1497_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","volume":"72","author":"G Mourad","year":"2001","unstructured":"Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, Durand D, Rostaing L, Lang P, et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2001;72(6):1050\u20135.","journal-title":"Transplantation."},{"issue":"3","key":"1497_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00007890-200202150-00025","volume":"73","author":"IA Agha","year":"2002","unstructured":"Agha IA, Rueda J, Alvarez A, Singer A, Miller GG, Brent W, Karen F, Lowell JA, Shenoy S, et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation. 2002;73(3):473\u20135.","journal-title":"Transplantation."},{"issue":"8","key":"1497_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1432-2277.2006.00270.x","volume":"19","author":"W Wong","year":"2006","unstructured":"Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, Cardarelli F, Winkelmayer WC, Cosimi AB, et al. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transplant Int. 2006;19(8):629\u201335.","journal-title":"Transplant Int"},{"issue":"10","key":"1497_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/TP.0b013e3181722fad","volume":"85","author":"RB Stevens","year":"2008","unstructured":"Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, et al. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation. 2008;85(10):1391\u20139.","journal-title":"Transplantation."},{"issue":"10","key":"1497_CR11","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/TP.0b013e31816dd596","volume":"85","author":"C Gurk-Turner","year":"2008","unstructured":"Gurk-Turner C, Airee R, Philosophe B, Kukuruga D, Drachenberg C, Haririan A. Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. Transplantation. 2008;85(10):1425\u201330.","journal-title":"Transplantation."},{"issue":"7","key":"1497_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/TP.0b013e3181b6f38c","volume":"88","author":"P Klem","year":"2009","unstructured":"Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Transplantation. 2009;88(7):891\u20136.","journal-title":"Transplantation."},{"issue":"7","key":"1497_CR13","first-page":"947","volume":"2010","author":"KL Hardinger","year":"2010","unstructured":"Hardinger KL, Rasu RS, Skelton R, Miller BW, Brennan DC. Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days? J Transp Secur. 2010;2010(7):947\u201352.","journal-title":"J Transp Secur"},{"issue":"2","key":"1497_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.transproceed.2011.01.035","volume":"43","author":"MR Laftavi","year":"2011","unstructured":"Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus Basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011;43(2):458\u201361.","journal-title":"Transplant Proc"},{"issue":"3","key":"1497_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/tri.12249","volume":"27","author":"H Longuet","year":"2014","unstructured":"Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, et al. Risk factors for impaired CD4? T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation. Transplant Int. 2014;27(3):271\u20139.","journal-title":"Transplant Int."},{"issue":"1","key":"1497_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/01.TP.0000164351.72220.1A","volume":"80","author":"R Calne","year":"2005","unstructured":"Calne R. \u201cPrope\u201d tolerance: induction, lymphocyte depletion with minimal maintenance. Transplantation. 2005;80(1):6\u20137.","journal-title":"Transplantation."},{"issue":"1","key":"1497_CR17","first-page":"1","volume":"4","author":"V Jain","year":"2017","unstructured":"Jain V, Sharma A, Halawa A. Inducing all our low risk transplant cadidates: shall we or shall we not? J Urol Nephrol. 2017;4(1):1\u20139.","journal-title":"J Urol Nephrol"},{"issue":"3","key":"1497_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2146\/ajhp090636","volume":"68","author":"S Gabaldi","year":"2011","unstructured":"Gabaldi S, Martin ST, Robertis KL, Grafals M. Induction immunosuppressive therapy in renal transplantation. Am J Health Syst Pharm. 2011;68(3):211\u20138.","journal-title":"Am J Health Syst Pharm"},{"issue":"7\u20138","key":"1497_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.humimm.2017.05.007","volume":"78","author":"HC Sullivan","year":"2017","unstructured":"Sullivan HC, Gebel HM, Bray RA. Understanding solid-phase HLA antibody assays and the value of MFI. Hum Immunol. 2017;78(7\u20138):471\u201380.","journal-title":"Hum Immunol"},{"issue":"12","key":"1497_CR20","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","volume":"3","author":"HM Gebel","year":"2003","unstructured":"Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003;3(12):1488\u201396.","journal-title":"Am J Transplant"},{"issue":"8","key":"1497_CR21","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1681\/ASN.2009101065","volume":"21","author":"C Lefuacheur","year":"2010","unstructured":"Lefuacheur C, Loupy A, Hill GS, Nochy D, Antoine C, Gastreau C, Charron D, Lotz DG, Suberbielle-Boissel CJ. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol. 2010;21(8):1398\u2013406.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1497_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","volume":"95","author":"BD Tait","year":"2013","unstructured":"Tait BD, S\u00fcsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FJJ, Reed EF, Bray RA, Campbell P, et al. Consensus guideline on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95(1):19\u201345.","journal-title":"Transplantation."},{"issue":"1","key":"1497_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.transproceed.2013.10.041","volume":"46","author":"E Nascimento","year":"2014","unstructured":"Nascimento E, Oliveira RAF, Maciel MD, Pereira AB, Lucas FM Jr, Salom\u00e3o-Filho A, Pereira WA, Moreira JB, Vila\u00e7a SS, et al. Kidney transplantation: evaluation and clinical outcome of 237 patients at low, medium, high or strong high risk of rejection. Transplant Proc. 2014;46(1):101\u20137.","journal-title":"Transplant Proc"},{"issue":"1","key":"1497_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","volume":"68","author":"RJ Duquesnoy","year":"2007","unstructured":"Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ and HLA-DP. Hum Immunol. 2007;68(1):12\u201325.","journal-title":"Hum Immunol"},{"issue":"4","key":"1497_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMoa071074","volume":"358","author":"T Kwai","year":"2008","unstructured":"Kwai T, Cosimi AB, Spitzer TR, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, et al. HLA-mismatched renal transplantation without maintenance immussupression. N Engl J Med. 2008;358(4):353\u201361.","journal-title":"N Engl J Med"},{"issue":"4","key":"1497_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MOT.0b013e3283636ddf","volume":"18","author":"C Susal","year":"2013","unstructured":"Susal C, Opelz G. The current role of human leukocyte antigen matching in kidney transplantation. Curr Opin Organ Transplant. 2013;18(4):438\u201344.","journal-title":"Curr Opin Organ Transplant"},{"key":"1497_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trre.2007.09.005","volume":"22","author":"R Marden","year":"2008","unstructured":"Marden R, Terenel JL. Patient outcome of kidney allograft loss. Transpl Rev. 2008;22:62\u20136.","journal-title":"Transpl Rev"},{"issue":"12","key":"1497_CR28","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/ajt.12478","volume":"13","author":"C Wiebe","year":"2013","unstructured":"Wiebe C, Pochinco D, Blydt-Hansen TD. Class II epitope matching: a strategy to minimize De novo donor-specific antibody development and improve outcomes. Am J Transplant. 2013;13(12):3114\u201322.","journal-title":"Am J Transplant"},{"issue":"3","key":"1497_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.transproceed.2018.02.007","volume":"50","author":"AHS Quintella","year":"2018","unstructured":"Quintella AHS, Lasmar ML, Fabreti-Oliveira RA, Nascimento E. Delayed graft function, predictive factors, and 7-year outcome of deceased donor kidney transplant recipients with different immunologic profiles. Transplant Proc. 2018;50(3):737\u201342.","journal-title":"Transplant Proc"},{"issue":"3","key":"1497_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","volume":"11","author":"KE Lamb","year":"2011","unstructured":"Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450\u201362.","journal-title":"Am J Transplant"},{"key":"1497_CR31","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1111\/j.1600-6143.2012.04236.x","volume":"12","author":"C Traynor","year":"2012","unstructured":"Traynor C, Jenkison A, Williams Y, O\u2019Kelly P, Hickey D, Denton M, Magee C, Conlon PJ. Twenty-year survivor of kidney transplantation. Am J Transplant. 2012;12:3289\u201395.","journal-title":"Am J Transplant"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.transproceed.2015.03.027","volume":"17","author":"F Rego","year":"2015","unstructured":"Rego F, Alcantara P, Buinho F. Gomes da Costa A, Rodrigues Pena J. long-term suvival (>25 years) of deceased donor kidney transplant recipient: A single-Center experience. Transplant Proc. 2015;17:967\u201370.","journal-title":"Transplant Proc"},{"issue":"9","key":"1497_CR33","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1016\/j.transproceed.2016.02.064","volume":"48","author":"E Nascimento","year":"2016","unstructured":"Nascimento E, Lucas-Junior FM, Fabreti-Oliveira RA, Vilela B, Tavora ER, Silva JP, Salom\u00e3o-Filho A. Kidney transplant with utralong-term (42 years) survival of a 100 year old graft. Transplant Proc. 2016;48(9):3079\u201384.","journal-title":"Transplant Proc"},{"issue":"2","key":"1497_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14(2):271\u201383.","journal-title":"Am J Transplant"},{"issue":"1","key":"1497_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/ajt.14107","volume":"17","author":"A Loupy","year":"2017","unstructured":"Loupy A, Hass M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, et al. The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. 2017;17(1):28\u20134.","journal-title":"Am J Transplant"},{"issue":"16","key":"1497_CR36","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2165\/11319260-000000000-00000","volume":"69","author":"R Marc\u00e9n","year":"2009","unstructured":"Marc\u00e9n R. Immunosuppresive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancies and infection. Drugs. 2009;69(16):2227\u201343.","journal-title":"Drugs."},{"issue":"2","key":"1497_CR37","doi-asserted-by":"publisher","first-page":"64S","DOI":"10.1016\/j.transproceed.2004.01.062","volume":"36","author":"AJ Matas","year":"2004","unstructured":"Matas AJ, Sutherland DE, Najarian JS. Evolution of immunosupressession at the University of Minnesota. Tranplant Proc. 2004;36(2):64S\u201370S.","journal-title":"Tranplant Proc"},{"issue":"1","key":"1497_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5935\/0101-2800.20140009","volume":"36","author":"R Sesso","year":"2014","unstructured":"Sesso R, Lopes AA, Thom\u00e9 FS, Lugon JR, Watanabe Y, dos Santos DR. Report of the Brazilian chronic Dialysis census 2012. J Bras Nefrol. 2014;36(1):48\u201353.","journal-title":"J Bras Nefrol"},{"issue":"1","key":"1497_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ncpneph0383","volume":"3","author":"S Baid-Agrawal","year":"2007","unstructured":"Baid-Agrawal S, Frei UA. Living donor renal transplantation:recent developments and perspectives. Nat Clin Prac Nephrol. 2007;3(1):31\u201341.","journal-title":"Nat Clin Prac Nephrol"},{"key":"1497_CR40","unstructured":"USRDS 2011- United States renal data system. Annual data report. National Institute of Diabetes and Digestive and Kidney Diseases. National Institute of health; 2011. https:\/\/www.usrds.org\/atlas11.aspx ."},{"issue":"11","key":"1497_CR41","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1681\/ASN.V11112141","volume":"11","author":"JA Bluestone","year":"2000","unstructured":"Bluestone JA, Matthews JB, Krensky AM. The immune tolerance network: the \u201choly grail\u201d comes to the clinic. J Am Soc Nephrol. 2000;11(11):2141\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1497_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","volume":"12","author":"C Wiebe","year":"2012","unstructured":"Wiebe C, Gilson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW. Evolution and clinical pathologic correlations of the de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12(5):1157\u201362.","journal-title":"Am J Transplant"},{"issue":"4","key":"1497_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.trim.2011.08.008","volume":"25","author":"LCDM Souza","year":"2011","unstructured":"Souza LCDM, Sales Filho HLA, Von Glem CQC, Silva AS, Santos Neto PA, Castro JAF, Silva AS, Castro AF, Monte SJH. EpHLA: an innovative and userfriendly software automating the HLAMatchmaker algorithm for antibody analysis. Transplant Immunol. 2011;25(4):210\u20136.","journal-title":"Transplant Immunol"},{"issue":"6","key":"1497_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrneph.2012.81","volume":"8","author":"A Loupy","year":"2012","unstructured":"Loupy A, Gary S, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol. 2012;8(6):348\u201357.","journal-title":"Nat Rev Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1497-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T15:38:55Z","timestamp":1664120335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1497-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1497-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol and informed consent form were approved by the Ethics Committee of human researches of the Hospital Santa Casa de Miseric\u00f3rdia of Belo Horizonte under permit #073\/2007. The informed consent form was signed by each participant prior enrollment, and was conducted based on the principles of the Helsinki and Istanbul Declarations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}